About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The research group in General Surgery aims to develop research activities in the field of Surgery from the most clinical and surgical aspects related to the quality of care to the most basic and translational aspects of etiopathogenesis, pathophysiology and the bases of the diseases included in its different areas of interest, as well as in the therapeutic procedures to address them. It is focused in several topics that include the fields of Abdominal Wall Surgery, biomaterials and bioengineering, Colorectal Surgery and Proctology, General Endocrine, Bariatric and Metabolic Surgery, Esophagogastric Surgery, and Thoracic Surgery. It includes clinical surgeons who make up the care teams of the various clinical lines and includes a basic research laboratory with two researchers with special interest in the study of the extracellular matrix and inflammation and biomaterials and their integration.
IP: Josep A Villena Delgado Collaborators: Angel Michael Ortiz Zúñiga, Laura Hidalgo Corbacho, Alba Rojano Toimil, Ramón Vilallonga Puy Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 217800 Reference: PID2021-123377OB-I00 Duration: 01/09/2022 - 31/08/2025
IP: Ramón Vilallonga Puy Collaborators: Mercedes Pérez Lafuente, Nuria Roson Gradaille, Laura Puente Ramo, Marta Comas Martínez, Alba Rojano Toimil, Arturo Cirera De Tudela, Elisa Merino Peña, Clara Pañella Vilamú, Ana Maria Ciscar Bellés, Carlos Petrola Chacón, Alba Maria Jiménez Masip Funding agency: Instituto de Salud Carlos III Funding: 171820 Reference: PI22/00880 Duration: 01/01/2023 - 31/12/2025
IP: Miriam de Nadal Clanchet Collaborators: Anna González Tallada, Alberto Jauregui Abularach, Maria Alonso Alonso Funding agency: Instituto de Salud Carlos III Funding: 119185 Reference: PI20/00154 Duration: 01/01/2021 - 30/06/2025
IP: Eloy Espín Basany Collaborators: Franco Marinello, Alejandro Solis Peña Funding agency: Instituto de Salud Carlos III Funding: 32670 Reference: PI20/00622 Duration: 01/01/2021 - 30/06/2025
Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research
This pathology, common among patients who have undergone rectal resection due to cancer, causes alterations in bowel function with great impact on quality of life.
The research has received funding from the Spanish Society of Obesity Surgery and the Spanish Association of Surgeons.
